Home › NDC Lookup › RxCUI directory › RxCUI 2102837

Salicylic acid 20 MG/ML Medicated Pad [Oxy Deep Pore] — RxCUI 2102837

RxNorm drug concept · Semantic branded drug
RxCUI 2102837 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2102837
Official nameSalicylic acid 20 MG/ML Medicated Pad [Oxy Deep Pore]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOxy Deep Pore 2 % Medicated Pad; Oxy Deep Pore 20 MG/ML Medicated Pad
FDA products mapped2
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Salicylic Acid Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used in a facial routine for acne-prone and oil-prone skin. The routine includes a cleanser, serum, toner and emulsion. Salicylic acid helps loosen and shed dead skin cells.
  • Use the cleanser morning and evening, and the serum in the morning after cleansing. Use the toner in the evening on dry skin, and the emulsion at night after cleansing. Avoid your...
  • Mild stinging, burning, itching, dryness and extra peeling can happen. If dryness or peeling bothers you, try using the serum or toner every other day. If it gets excessive, stop a...
  • It is best not to. Using another topical acne medication at the same time makes irritation and dryness more likely. If you get irritated, use only one at a time.
📖 Read our full Salicylic Acid Topical guide →

🕸️ Concept Web — How Salicylic acid 20 MG/ML Medicated Pad [Oxy Deep... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Salicylic acid 20 MG/ML Medicated Pad [Oxy Deep Pore] RxCUI 2102837

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Salicylic acid 9525
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Oxy Deep Pore 2102832
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Salicylic acid Medicated Pad 797884
    • Salicylic acid Medicated Pad or Tape 1157597
    • Salicylic acid Topical Product 1157604
    • Salicylic acid Medicated Pad [Oxy Deep Pore] 2102834
    • Oxy Deep Pore Medicated Pad or Tape 2102835
    • Oxy Deep Pore Topical Product 2102836
    • Medicated Pad 797271
    • Medicated Pad or Tape 1151124
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {1 (benzoyl peroxide 50 MG/ML Medicated Pad) / 1 (salicylic acid 20 MG/ML Medicated Pad) } Pack 999473

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Salicylic acid 20 MG/ML Medicated Pad SCD · 797892
  • Salicylic acid 20 MG/ML SCDC · 328925
  • Salicylic acid Medicated Pad SCDF · 797884
  • Salicylic acid Medicated Pad or Tape SCDG · 1157597
  • Salicylic acid Topical Product SCDG · 1157604
  • {1 (benzoyl peroxide 50 MG/ML Medicated Pad) / 1 (salicylic acid 20 MG/ML Medicated Pad) } Pack GPCK · 999473

Brand-Name Concepts

  • Salicylic acid 20 MG/ML [Oxy Deep Pore] SBDC · 2102833
  • Salicylic acid Medicated Pad [Oxy Deep Pore] SBDF · 2102834
  • Oxy Deep Pore Medicated Pad or Tape SBDG · 2102835
  • Oxy Deep Pore Topical Product SBDG · 2102836
  • Oxy Deep Pore BN · 2102832

📦 FDA Products & Package NDCs

2 products · 6 package NDCs
6 package NDCs map to RxCUI 2102837 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10742-1200-01 90 SWAB in 1 JAR (10742-1200-1) OXY ADVANCED CARE MAXIMUM STRENGTH 3-in-1 ACNE PADS The Mentholatum Company 2021-10-01
10742-1200-02 104 SWAB in 1 JAR (10742-1200-2) OXY ADVANCED CARE MAXIMUM STRENGTH 3-in-1 ACNE PADS The Mentholatum Company 2021-10-01
10742-4204-01 90 SWAB in 1 JAR (10742-4204-1) OXY Deep Pore Cleansing Pads The Mentholatum Company 2018-06-01
10742-4204-02 104 SWAB in 1 JAR (10742-4204-2) OXY Deep Pore Cleansing Pads The Mentholatum Company 2022-06-15
10742-4204-04 55 SWAB in 1 JAR (10742-4204-4) OXY Deep Pore Cleansing Pads The Mentholatum Company 2022-06-15
10742-4204-05 70 SWAB in 1 JAR (10742-4204-5) OXY Deep Pore Cleansing Pads The Mentholatum Company 2022-06-15
Observed labelers: The Mentholatum Company (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.